Drugs / Immune Globulin IV (Human)
Immune Globulin IV (Human)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00220740 | Apr 2004 → Jun 2006 | chronic inflammatory demyelinating polyradiculoneuropathy | Grifols Therapeutics LLC | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immune Globulin IV (Human) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00220740 ↗ |
| Modality | Protein / enzyme biologic | “immune globulin intravenous, 10% caprylate-chromatography purified” PMID 19260050 ↗ Apr 2009 |
| Route | Intravenous | “intravenous immunoglobulin (10% caprylate-chromatography purified)” PMID 19496683 ↗ Jun 2009 |